Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ly2940680
2. Taledegib
1. 1258861-20-9
2. Ly2940680
3. Ly-2940680
4. 4-fluoro-n-methyl-n-(1-(4-(1-methyl-1h-pyrazol-5-yl)phthalazin-1-yl)piperidin-4-yl)-2-(trifluoromethyl)benzamide
5. Ly 2940680
6. Qy8bwx1lj5
7. Taladegib (ly2940680)
8. 4-fluoro-n-methyl-n-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-2-(trifluoromethyl)benzamide
9. 4-fluoro-n-methyl-n-{1-[4-(1-methyl-1h-pyrazol-5-yl)phthalazin-1-yl]piperidin-4-yl}-2-(trifluoromethyl)benzamide
10. Benzamide, 4-fluoro-n-methyl-n-(1-(4-(1-methyl-1h-pyrazol-5-yl)-1-phthalazinyl)-4-piperidinyl)-2-(trifluoromethyl)-
11. 4-fluoro-n-methyl-n-(1-(4-(1-methyl-1h-pyrazol-5-yl)-1-phthalazinyl)-4-piperidinyl)-2-(trifluoromethyl)benzamide
12. Benzamide, 4-fluoro-n-methyl-n-[1-[4-(1-methyl-1h-pyrazol-5-yl)-1-phthalazinyl]-4-piperidinyl]-2-(trifluoromethyl)-
13. Taladegib [usan:inn]
14. Unii-qy8bwx1lj5
15. Taladegib [inn]
16. 4-fluoro-n-methyl-n-{1-[4-(1-methyl-1h-pyrazol-5-yl)-1-phthalazinyl]-4-piperidinyl}-2-(trifluoromethyl)benzamide
17. Taladegib (usan/inn)
18. Taladegib [usan]
19. Taladegib [who-dd]
20. Mls006011066
21. Ly-2940680(taladegib)
22. Schembl2128615
23. Chembl2142592
24. Gtpl10333
25. Dtxsid50154986
26. Ex-a156
27. Bcp02512
28. Bdbm50545020
29. Mfcd21609264
30. Nsc767896
31. S2157
32. Zinc68247898
33. Akos026674116
34. Bcp9000881
35. Ccg-269788
36. Cs-0459
37. Db12550
38. Nsc-767896
39. Sb16504
40. Ncgc00263170-01
41. Ncgc00263170-06
42. Ac-33096
43. As-75020
44. Hy-13242
45. Smr004702857
46. D10671
47. J-515412
48. Q27287564
49. 1ks
| Molecular Weight | 512.5 g/mol |
|---|---|
| Molecular Formula | C26H24F4N6O |
| XLogP3 | 4.3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 4 |
| Exact Mass | 512.19477206 g/mol |
| Monoisotopic Mass | 512.19477206 g/mol |
| Topological Polar Surface Area | 67.2 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 794 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Taladegib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Taladegib, including repackagers and relabelers. The FDA regulates Taladegib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Taladegib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Taladegib supplier is an individual or a company that provides Taladegib active pharmaceutical ingredient (API) or Taladegib finished formulations upon request. The Taladegib suppliers may include Taladegib API manufacturers, exporters, distributors and traders.
Taladegib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Taladegib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Taladegib GMP manufacturer or Taladegib GMP API supplier for your needs.
A Taladegib CoA (Certificate of Analysis) is a formal document that attests to Taladegib's compliance with Taladegib specifications and serves as a tool for batch-level quality control.
Taladegib CoA mostly includes findings from lab analyses of a specific batch. For each Taladegib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Taladegib may be tested according to a variety of international standards, such as European Pharmacopoeia (Taladegib EP), Taladegib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Taladegib USP).
LOOKING FOR A SUPPLIER?
